SEARCH

SEARCH BY CITATION

References

  • 1
    Shorvon SD. Status epilepticus: its clinical features and treatment in children and adults. Cambridge : Cambridge University Press, 1994.
  • 2
    Aminoff MJ, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. American Journal of Medicine 1980; 69: 65766.
  • 3
    De Giorgio CM, Tomiyasu U., Gott PS, Treiman DM. Hippo–campal pyramidal cell loss in human status epilepticus. Epilepsia 1992; 33: 237.
  • 4
    Delgado–Escueta AV, Enrile–Bacsal F. Combination therapy for status epilepticus: intravenous diazepam and phenytoin. In: Delgado–EscuetaAV, WasterlainCG, TreimanDM, PorterRJ eds. Status epilepticus: mechanisms of brain damage and treatment. Advances in neurology, vol 34. New York : Raven Press, 1983; 47785.
  • 5
    Shaner DM, Mccurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988; 38: 2027.
  • 6
    Pascual J., Ciudad J., Berciano J. Role of lidocaine (ligno–caine) in managing status epilepticus. Journal of Neurology, Neurosurgery and Psychiatry 1992; 55: 4951.
  • 7
    Treiman DM. The role of benzodiazepines in the management of status epilepticus. Neurology 1990; 40: 3242.
  • 8
    Leppik IE, Derivan AT, Homan RW, Walker J., Ramsay RE, Patrick B. Double–blind study of lorazepam and diazepam in status epilepticus. Journal of American Medical Association 1983; 249: 14524.
  • 9
    Ramsay RE. Treatment of status epilepticus. Epilepsia 1993; 34 (Suppl. 1): S71S81.
  • 10
    Shorvon S. Tonic clonic status epilepticus. Journal of Neurology, Neurosurgery and Psychiatry 1993; 56: 12534.
  • 11
    Anonymous. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. Journal of American Medical Association 1993; 270: 8549.
  • 12
    Jagoda A., Riggio S. Refractory status epilepticus in adults. Annals of Emergency Medicine 1993; 22: 133748.
  • 13
    Simon RP. Physiological consequences of status epilepticus. Epilepsia 1985; 26 (Suppl. 1): S5866.
  • 14
    Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates. Ischaemic cell change and its relation to ictal physiological events. Archives of Neurology 1973; 28: 1017.
  • 15
    Meldrum BS, Vigouroux RA, Brierley JB. Systemic factors and epileptic brain damage. Prolonged seizures in paralysed, artificially ventilated baboons. Archives of Neurology 1973; 29: 827.
  • 16
    Olney JW, Collins RC, Sloviter RS. Excitotoxic mechanisms of epileptic brain damage. In: Delgado–EscuetaAV, WardAA, WoodburyDM, PorterRJ eds. Basic mechanisms of the epilepsies, molecular and cellular approaches. Advances in neurology, vol 44. New York : Raven Press, 1986. 85777.
  • 17
    Treiman DM. Generalised convulsive status epilepticus in the adult. Epilepsia 1993; 34 (Suppl. 1): S2S11.
  • 18
    Gastaut H., Courjon J. Poire R, Weber M. Treatment of status epilepticus with a new benzodiazepine more active than diazepam. Epilepsia 1971; 12: 197214.
  • 19
    Rivera R., Segnini M., Baltodano A., Perez V. Midazolam in the treatment of status epilepticus in children. Critical Care Medicine 1993; 21: 9914.
  • 20
    Kumar A., Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Critical Care Medicine 1992; 20: 4838.
  • 21
    Schmidt D. Diazepam. In: LevyR., MattsonR., MeldrumB., PenryJK, DreifussFE eds. Antiepileptic drugs, 3rd edn. New York : Raven Press, 1989; 73564.
  • 22
    Greenblatt DJ, Miller LG, Shader RI. Clonazepam pharmacokinetics, brain uptake, and receptor interactions. Journal of Clinical Psychiatry 1987; 48 (Suppl.): 49.
  • 23
    Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam: a review of its pharmacological properties and therapeutic use. Drugs 1984; 28: 51943.
  • 24
    Walton NY, Treiman DM. Phenobarbital treatment of status epilepticus in a rodent model. Epilepsy Research 1989; 4: 21621.
  • 25
    Browne TR. Paraldehyde, Chlormethiazole and Lidocaine for treatment of status epilepticus. In: Delgado–EscuetaAV, WasterlainCG, TreimanDM, PorterRJ eds. Status epilepticus: mechanisms of brain damage and treatment. Advances in Neurology, vol 34. New York : Raven Press, 1983; 50917.
  • 26
    Pentikainen PJ, Valtonen VV, Miettinen TA. Deaths in connection with chlormethiazole (Heminevrin) therapy. International Journal of Clinical Pharmacology and Biophar–maceutics 1976; 14: 22530.
  • 27
    Robson DJ, Blow C., Gaines P., Flanagan RJ, Henry JA. Accumulation of chlormethiazole during intravenous infusion. Intensive Care Medicine 1984; 10: 31516.
  • 28
    Burstein CL. The hazard of paraldehyde administration: clinical and laboratory studies. Journal of American Medical Association 1943; 121: 18790.
  • 29
    Link MJ, Anderson RE, Meyer FB. Effects of magnesium sulfate on pentylenetetrazol–induced status epilepticus. Epilepsia 1991; 32: 5439.
  • 30
    Vajda FJ. Valproic acid in the treatment of status epilepticus. In: Delgado–EscuetaAV, WasterlainCG, TreimanDM, PorterRJ eds. Status epilepticus: mechanisms of brain damage and treatment. Advances in neurology, vol 34. New York : Raven Press, 1983; 51929.
  • 31
    Poulton TJ, Ellingson RJ. Seizure associated with induction of anesthesia with isoflurane. Anesthesiology 1984; 61: 4716.
  • 32
    Makela JP, Iivanainen M., Pieninkeroinen IP, Waltimo O., Lahdensuu M. Seizures associated with propofol anaesthesia. Epilepsia 1993; 34: 8325.
  • 33
    Hodkinson BP, Frith RW, Mee EW. Propofol and the electroencephalogram. Lancet 1987; 2: 1518.
  • 34
    Opitz A., Marschall M., Degen R., Koch D. General anesthesia in patients with epilepsy and status epilepticus. In: Delgado–EscuetaAV, WasterlainCG, TreimanDM, PorterRJ eds. Status epilepticus: mechanisms of brain damage and treatment. Advances in Neurology, vol 34. New York : Raven Press, 1983; 5315.
  • 35
    Brown AS, Horton JM. Status epilepticus treated by intravenous infusions of thiopentone sodium. British Medical Journal 1967; 1: 278.
  • 36
    Turcant A., Delhumeau A., Premel–Cabic A., Granry J–C, Cottineau C., Six P., Allain P. Thiopental pharmacokinetics under conditions of long–term infusion. Anesthesiology 1985; 63: 5054.
  • 37
    Dundee JW, Gray RC. Thiopentone in status epilepticus. British Medical Journal 1967; 1: 362.
  • 38
    Yaffe K., Lowenstein DH. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 1993; 43: 895900.
  • 39
    Van Ness PC. Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 1990; 31: 617.
  • 40
    Mackenzie SJ, Kapadia F., Grant IS. Propofol infusion for control of status epilepticus. Anaesthesia 1990; 45: 10435.
  • 41
    Campostrini R., Bati MB, Giorgi C., Palumbo P., Serra P., Vinattieri A., Cantini A., Martini E. Propofol in the treatment of convulsive status epilepticus: a report of four cases. Rivista di Neurologia 1991; 61: 1769.
  • 42
    De Riu PL, Petruzzi V., Testa C., Mulas M., Melis F., Caria MA, Mameli O. Propofol anticonvulsant activity in experimental epileptic status. British Journal of Anaesthesia 1992; 69: 17781.
  • 43
    Hilz MJ, Bauer J., Claus D., Stefan H., Neundorfer B. Isoflurane anaesthesia in the treatment of convulsive status epilepticus. Journal of Neurology 1992; 239: 1357.
  • 44
    Meeke RI, Soifer BE, Gelb AW. Isoflurane for the management of status epilepticus. Drug Intelligence and Clinical Pharmacy 1989; 23: 57981.
  • 45
    Kofke WA, Young RSK, Davis P., Woelfel SK, Gray L., Johnson D., Gelb A., Meeke R., Warner DS, Pearson KS, Gibson JR, Koncelik J., Wessel HB. Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology 1989; 71: 6539.
  • 46
    Wauquier A. A profile of etomidate. A hypnotic anticonvulsant and brain protective compound. Anaesthesia 1983; 38 (Suppl.): 2633.
  • 47
    Yeoman P., Hutchinson A., Byrne A., Smith J., Durham S. Etomidate infusions for the control of refractory status epilepticus. Intensive Care Medicine 1989; 15: 2559.
  • 48
    Treiman DM, De Giorgio CM, Salisbury SM, Wickboldt CL. Subtle generalised convulsive status epilepticus. Epilepsia 1984; 25: 653.
  • 49
    Rashkin MC, Youngs C., Penovich P. Pentobarbital treatment of refractory status epilepticus. Neurology 1987; 37: 5003.
  • 50
    Lowenstein DH, Aminoff MJ, Simon RP. Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology 1988; 38: 395400.
  • 51
    Leis AA, Ross MA, Summers AK. Psychogenic seizures: ictal characteristics and diagnostic pitfalls. Neurology 1992; 42: 959.
  • 52
    Howell SJ, Owen L., Chadwick DW. Pseudostatus epilepticus. Quarterly Journal of Medicine 1989; 71: 50719.
  • 53
    Treiman D., Tyrrell E., Lee J., Ben–Menachem E., Nelson L., Weil M., Shields W., Mendius J. Chugani H, Locke G, Her–FWDAHL L, Clark M, Barber K. Lorazepam versus phenytoin in the treatment of major motor status epilepticus. A preliminary report. Epilepsia 1983; 24: 520.